SCHEMBL29802502

SCHEMBL29802502

Clc1ccc2ncn(Cc3cccs3)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.40
▸ FGFR4 P22455 1/20 0.40
▸ ALDH1A1 P00352 8/20 0.39
▸ HPGD P15428 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 6/20 0.36
▸ HSD17B10 Q99714 6/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP1A2 P05177 8/20 0.36
▸ CYP3A4 P08684 7/20 0.36
▸ CYP2D6 P10635 6/20 0.36
▸ CYP2C19 P33261 5/20 0.36
▸ CASP1 P29466 4/20 0.36
▸ CYP2C9 P11712 4/20 0.36
▸ CASP7 P55210 3/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MET P08581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23093442 1.00 FGFR1 (0.40) FGFR1FGFR4ALDH1A1HPGDKDM4E
SCHEMBL23093469 0.82 CYP1A2 (0.43) FGFR1FGFR4ALDH1A1HPGDTSHR
SCHEMBL23093463 0.80 CYP1A2 (0.40) ALDH1A1HPGDKDM4ESMN1; SMN2TSHR
SCHEMBL23093159 0.78 DRD4 (0.38) HPGDKDM4ESMN1; SMN2TSHRHSD17B10
SCHEMBL29802514 0.78 DRD4 (0.38) HPGDKDM4ESMN1; SMN2TSHRHSD17B10
SCHEMBL9798126 0.72 HDAC6 (0.53) —
SCHEMBL9674199 0.72 CYP11B1 (0.58) ALDH1A1HPGDKDM4ESMN1; SMN2POLB
SCHEMBL29802500 0.70 NR3C1 (0.43) ALDH1A1HPGDKDM4ESMN1; SMN2TSHR
SCHEMBL23093119 0.70 NR3C1 (0.43) ALDH1A1HPGDKDM4ESMN1; SMN2TSHR
SCHEMBL31720305 0.70 FGFR1 (0.42) FGFR1FGFR4SMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4027993-A1 CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF The Broad Institute Inc. (US) 2022-07-20 — — EP disclosed
Send feedback